Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06361719
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-04-08
Brief Title:
Efficacy of Two HMOs in Chinese Infants
Sponsor:
Société des Produits Nestlé SPN
Organization:
Société des Produits Nestlé SPN
Study Overview
Official Title:
Efficacy of a Ready to Feed RTF Starter Liquid Infant Formula Containing 2FL and LNnT in Chinese Infants A Double-blind Randomized Controlled Trial Including a Breastfed Reference Group
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized controlled double-blind intervention trial of healthy male and female term infants to evaluate the efficacy of the 2 HMOs on beneficially modulating the gut microbiota gut maturation gut barrier integrity immune response and other developmental outcomes in healthy Chinese infants The trial consists of 2 randomized formula-fed groups and a non-randomized breastfed reference group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None